Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • anda

    Tag: anda

    You Searched For "anda"
    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Medical Dialogues Bureau27 March 2020 1:11 PM IST
    Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias, and angina.
    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Medical Dialogues Bureau14 Nov 2019 9:30 AM IST
    Managing director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Medical Dialogues Bureau3 Nov 2019 10:00 AM IST
    Glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Medical Dialogues Bureau28 Sept 2019 2:38 PM IST
    "Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Medical Dialogues Bureau19 Sept 2019 9:35 AM IST
    New Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Medical Dialogues Bureau7 Aug 2019 9:30 AM IST
    Amphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
    Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

    Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

    Medical Dialogues Bureau3 Aug 2019 9:45 AM IST
    Minocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-modular moderate to severe acne vulgaris in...
    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Medical Dialogues Bureau25 July 2019 11:23 AM IST
    In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
    Laurus Labs, Rising Pharma launches neuropathic pain capsules in US

    Laurus Labs, Rising Pharma launches neuropathic pain capsules in US

    Medical Dialogues Bureau23 July 2019 9:30 AM IST
    Rising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
    USFDA issues warning letter to Indoco Remedies for Goa plant

    USFDA issues warning letter to Indoco Remedies for Goa plant

    Medical Dialogues Bureau16 July 2019 11:39 AM IST
    The facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Farhat Nasim2 July 2019 11:49 AM IST
    The approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Farhat Nasim24 Jun 2019 12:25 PM IST
    The approved product, Bromfenac Ophthalmic Solution is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution,...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok